{"url_path":"/sec/ctnm/8-k/2026-06-26/item-5-07","section_key":"item-5-07","section_title":"Item 5.07 Submission of Matters to a Vote of Security Holders.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-26","source_url":"https://www.sec.gov/Archives/edgar/data/1855175/0001628280-26-045804-index.html","accession_number":"0001628280-26-045804","cik":"0001855175","ticker":"CTNM","issuer_name":"Contineum Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1855175/0001628280-26-045804-index.html","primary_entity_key":"0001855175","primary_entity_name":"Contineum Therapeutics, Inc."},"word_count":251,"has_tables":true,"body_markdown":"Item 5.07 Submission of Matters to a Vote of Security Holders.\n\nOn June 26, 2026, Contineum Therapeutics, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”). As of April 27, 2026, the record date for the Annual Meeting, there were 32,723,877 shares of Class A common stock outstanding and entitled to vote at the Annual Meeting. The Annual Meeting was conducted virtually, and the following is a brief summary of the matters voted upon by stockholders at the Annual Meeting.\n\nProposal 1: Election of Directors\n\nThe Company’s stockholders elected the three persons listed below as Class II directors, each to serve until the Company’s 2029 Annual Meeting of Stockholders or until their respective successors have been elected or appointed. The final voting results are as follows:\n\nDirector NomineeVotes ForVotes WithheldBroker Non-Votes\n\nEvert Schimmelpennink21,773,559131,3846,133,812\n\nLori M. Lyons-Williams20,593,7151,311,2286,133,812\n\nDiego Miralles, M.D.21,673,187231,7566,133,812\n\nProposal 2: Ratification of the Appointment of Independent Registered Public Accounting Firm\n\nThe Company’s stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The final voting results are as follows:\n\nVotes ForVotes AgainstVotes WithheldBroker Non-Votes\n\n28,021,04716,1041,604N/A\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\nDate: June 26, 2026\n\nContineum Therapeutics, Inc.\n\nBy: /s/ Peter Slover\n\nPeter Slover\n\nChief Financial Officer\n\nPrincipal Financial Officer and Principal Accounting Officer"}